Bacillary angiomatosis in an immunocompetent individual

Nikam, Balkrishna P; Vijayendran, Natasha; Jamale, Varsha; Kale, Mohan

doi:10.4103/idoj.idoj_139_17

Cited by 5 publications

(2 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Second, cBA lesions can be mistaken for similar ones due to both infective (e.g., Mycobacterium spp., Nocardia spp., Sporothrix spp., Histoplasma spp.) or other (e.g., neoplasm, trauma) causes [ 8 , 11 , 14 , 15 ]. Third, Bartonella spp.…”

Section: Discussionmentioning

confidence: 99%

A systematic review on antibiotic therapy of cutaneous bacillary angiomatosis not related to major immunocompromising conditions: from pathogenesis to treatment

Rotundo,

Tassone,

Marascio

et al. 2024

BMC Infect Dis

View full text Add to dashboard Cite

Background Cutaneous bacillary angiomatosis (cBA) is a vascular proliferative disorder due to Bartonella spp. that mostly affects people living with HIV (PLWH), transplanted patients and those taking immunosuppressive drugs. Since cBA is mostly related to these major immunocompromising conditions (i.e., T-cell count impairment), it is considered rare in relatively immunocompetent patients and could be underdiagnosed in them. Moreover, antimicrobial treatment in this population has not been previously investigated. Methods We searched the databases PubMed, Google Scholar, Scopus, OpenAIRE and ScienceDirect by screening articles whose title included the keywords “bacillary” AND “angiomatosis” and included case reports about patients not suffering from major immunocompromising conditions to provide insights about antibiotic treatments and their duration. Results Twenty-two cases of cBA not related to major immunocompromising conditions were retrieved. Antibiotic treatment duration was shorter in patients with single cBA lesion than in patients with multiple lesions, including in most cases macrolides and tetracyclines. Conclusions cBA is an emerging manifestation of Bartonella spp. infection in people not suffering from major immunocompromising conditions. Until evidence-based guidelines are available, molecular tests together with severity and extension of the disease can be useful to personalize the type of treatment and its duration.

show abstract

Section: Discussionmentioning

confidence: 99%

A systematic review on antibiotic therapy of cutaneous bacillary angiomatosis not related to major immunocompromising conditions: from pathogenesis to treatment

Rotundo,

Tassone,

Marascio

et al. 2024

BMC Infect Dis

View full text Add to dashboard Cite

show abstract

“…The occurrence of BA in immunocompetent patients is limited to case reports, a few from India. [ 2 3 ] Table 1 summarizes the cases of BA in immunocompetent patients. [ 4 5 6 7 8 9 ] There is a slight female predominance (M: F = 4:5) with an age range of 10 to 65 years.…”

mentioning

confidence: 99%

Bacillary Angiomatosis in an Immunocompetent Patient

Agrawal

Singal

Arora

2022

Indian Dermatology Online Journal

View full text Add to dashboard Cite

Bacterial Infections

Wootton,

Elliott

2024

Rook's Textbook of Dermatology

View full text Add to dashboard Cite

The skin provides a barrier between the body and the external environment and it is colonised by the bacteria and other microorganisms that make up the skin microbiome. Bacterial infections occur when bacteria invade through damage to the skin barrier, via trauma or pre‐existing skin conditions, or through inoculation or inhalation; bacterial skin infections can range from minor irritations to life‐threatening conditions. This chapter explores bacterial infections which can affect the skin, from the common to the rare, describing the epidemiology, presentation and management of each condition.

show abstract

Bacillary angiomatosis in an immunocompetent individual

Cited by 5 publications

References 4 publications

A systematic review on antibiotic therapy of cutaneous bacillary angiomatosis not related to major immunocompromising conditions: from pathogenesis to treatment

A systematic review on antibiotic therapy of cutaneous bacillary angiomatosis not related to major immunocompromising conditions: from pathogenesis to treatment

Bacillary Angiomatosis in an Immunocompetent Patient

Bacterial Infections

Contact Info

Product

Resources

About